# Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis

> **NCT01066364** · PHASE2 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 59 (actual)

## Conditions studied

- Nonalcoholic Steatohepatitis

## Interventions

- **DRUG:** Colesevelam Hcl

## Key facts

- **NCT ID:** NCT01066364
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2020-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01066364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01066364, "Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01066364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*